ArriVent BioPharma, Inc.
AVBP
$20.82
-$0.35-1.65%
NASDAQ
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | 45.53% | 70.03% | 63.36% | 94.28% | -7.95% |
| Total Receivables | -34.30% | -54.09% | 190.70% | -- | 52.20% |
| Inventory | -- | -- | -- | -- | -- |
| Prepaid Expenses | 10.60% | 298.95% | 186.21% | -- | 10.51% |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | -14.69% | -35.47% | -48.13% | -- | -54.12% |
| Total Current Assets | 41.89% | 62.46% | 55.28% | -- | -12.40% |
|
|
|||||
| Total Current Assets | 41.89% | 62.46% | 55.28% | -- | -12.40% |
| Net Property, Plant & Equipment | -47.08% | 325.00% | 188.16% | -- | 109.35% |
| Long-term Investments | -- | -- | -- | -- | -- |
| Goodwill | -- | -- | -- | -- | -- |
| Total Other Intangibles | -- | -- | -- | -- | -- |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | -95.56% | -93.58% | 52.44% | -- | 3,843.06% |
| Total Assets | 68.57% | 60.84% | 55.33% | -- | -10.79% |
|
|
|||||
| Total Accounts Payable | -16.55% | -3.57% | -40.97% | -- | 46.48% |
| Total Accrued Expenses | 91.74% | 97.77% | 29.54% | -- | 35.31% |
| Short-term Debt | -- | -- | -- | -- | -- |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | 15.71% | 256.82% | 100.00% | -- | 9.38% |
| Total Finance Division Other Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Current Liabilities | -- | -- | -- | -- | -- |
| Total Current Liabilities | 48.61% | 50.12% | -5.58% | -- | 39.04% |
|
|
|||||
| Total Current Liabilities | 48.61% | 50.12% | -5.58% | -- | 39.04% |
| Long-Term Debt | -- | -- | -- | -- | -- |
| Short-term Debt | -- | -- | -- | -- | -- |
| Capital Leases | -92.09% | -- | -- | -- | 1,509.09% |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | -- | -- | -- | -- | -- |
| Total Liabilities | 46.50% | 50.67% | -4.82% | -- | 40.97% |
|
|
|||||
| Common Stock & APIC | 10,566.34% | 11,820.87% | 12,922.02% | -- | 36.70% |
| Retained Earnings | -50.99% | -59.31% | -61.26% | -- | -78.33% |
| Treasury Stock & Other | -- | -- | -- | -- | -- |
| Total Common Equity | 268.19% | 309.26% | 350.43% | 473.31% | -80.00% |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | -- | 17.31% |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | -- | -- | 17.31% |
|
|
|||||
| Total Common Equity | 268.19% | 309.26% | 350.43% | 473.31% | -80.00% |
| Total Preferred Equity | -- | -- | -- | -- | 17.31% |
| Total Minority Interest | -- | -- | -- | -- | -- |
| Total Equity | 70.30% | 61.44% | 59.47% | 82.12% | -13.28% |
|
|
|||||